Preparatory phase for clinical trials of COVID-19 vaccine in Nepal

Abstract

Public health data suggested a rapid rise in COVID-19-confirmed cases in Nepal along with increased deaths. There has been a wide variation in clinical outcomes of this disease. Control of this pandemic depends on the availability of vaccines or drugs for SARS-CoV-2. Thus, viral and human genetics/genomics and immunology are necessary to understand whether these factors will affect clinical trials of vaccines in Nepal.

Keywords

• covid-19
• vaccines
• clinical manifestations
• asymptomatic infections
• molecular diagnostics
• nepal